131 related articles for article (PubMed ID: 33164549)
21. Central and peripheral haemodynamics at exercise onset: the role of central command.
Giuriato G; Ives SJ; Tarperi C; Bortolan L; Ruzzante F; Cevese A; Schena F; Venturelli M
Eur J Appl Physiol; 2024 May; ():. PubMed ID: 38819659
[TBL] [Abstract][Full Text] [Related]
22. Does Grappling Combat Sports Experience Influence Exercise Tolerance of Handgrip Muscles in the Severe-Intensity Domain?
Junior RC; Barreto RV; Oliveira AS; Greco CC
Sports (Basel); 2024 Feb; 12(3):. PubMed ID: 38535729
[TBL] [Abstract][Full Text] [Related]
23. The Influence of Cold Therapy on the Physical Working Capacity at the Electromyographic Threshold for Consecutive Exercise Sessions.
Maasri RE; Jarvie JR; Karski JS; Smith LJ; Malek MH
Bioengineering (Basel); 2024 Mar; 11(3):. PubMed ID: 38534566
[TBL] [Abstract][Full Text] [Related]
24. Intermittent treatment with elamipretide preserves exercise tolerance in aged female mice.
Campbell MD; Samuelson AT; Chiao YA; Sweetwyne MT; Ladiges WC; Rabinovitch PS; Marcinek DJ
Geroscience; 2023 Aug; 45(4):2245-2255. PubMed ID: 36840897
[TBL] [Abstract][Full Text] [Related]
25. Decoding the Pathophysiology of HFpEF With High-Resolution Phenotyping.
Houstis NE
JACC Basic Transl Sci; 2020 Mar; 5(3):226-228. PubMed ID: 32215376
[TBL] [Abstract][Full Text] [Related]
26. The Farm to Table HFpEF Kitchen: Selecting the Right Ingredients for the Discerning Palate.
Ambardekar AV; Kopecky BJ
JACC Basic Transl Sci; 2024 Mar; 9(3):300-302. PubMed ID: 38559628
[TBL] [Abstract][Full Text] [Related]
27. PARIS: A good start for exercise in HFPEF.
Elamragy AA
Glob Cardiol Sci Pract; 2014; 2014(3):249-53. PubMed ID: 25763377
[No Abstract] [Full Text] [Related]
28. Central Command and the Regulation of Exercise Heart Rate Response in Heart Failure With Preserved Ejection Fraction.
Sarma S; Howden E; Lawley J; Samels M; Levine BD
Circulation; 2021 Feb; 143(8):783-789. PubMed ID: 33205661
[TBL] [Abstract][Full Text] [Related]
29. Direct Assessment of Muscle Sympathetic Nerve Activity During Exercise in Heart Failure With Preserved Ejection Fraction: A Case Report.
Bunsawat K; Ratchford SM; Alpenglow JK; Ryan JJ; Richardson RS; Wray DW
J Card Fail; 2021 Jan; 27(1):114-116. PubMed ID: 33166658
[No Abstract] [Full Text] [Related]
30. Targeting Mitochondria-Inflammation Circuit by β-Hydroxybutyrate Mitigates HFpEF.
Deng Y; Xie M; Li Q; Xu X; Ou W; Zhang Y; Xiao H; Yu H; Zheng Y; Liang Y; Jiang C; Chen G; Du D; Zheng W; Wang S; Gong M; Chen Y; Tian R; Li T
Circ Res; 2021 Jan; 128(2):232-245. PubMed ID: 33176578
[TBL] [Abstract][Full Text] [Related]
31. The Effect of Sacubitril-Valsartan in Heart Failure Patients With Mid-Range and Preserved Ejection Fraction: A Meta-Analysis.
Nie D; Xiong B; Qian J; Rong S; Yao Y; Huang J
Heart Lung Circ; 2021 May; 30(5):683-691. PubMed ID: 33199181
[TBL] [Abstract][Full Text] [Related]
32. Coronary microvascular dysfunction in heart failure with preserved ejection fraction: not the end but the end of the beginning.
D'Amario D; Borovac JA; Crea F
Eur J Heart Fail; 2021 May; 23(5):773-775. PubMed ID: 33247863
[No Abstract] [Full Text] [Related]
33. Heart failure development in obesity: underlying risk factors and mechanistic pathways.
Jamaly S; Carlsson L; Peltonen M; Andersson-Assarsson JC; Karason K
ESC Heart Fail; 2021 Feb; 8(1):356-367. PubMed ID: 33231382
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of the H
Ludwig S; Pellegrini C; Gossling A; Rheude T; Voigtländer L; Bhadra OD; Linder M; Kalbacher D; Koell B; Waldschmidt L; Schirmer J; Seiffert M; Reichenspurner H; Blankenberg S; Westermann D; Conradi L; Joner M; Schofer N
ESC Heart Fail; 2021 Feb; 8(1):461-470. PubMed ID: 33215870
[TBL] [Abstract][Full Text] [Related]
35. Sacubitril-valsartan improves conduit vessel function and functional capacity and reduces inflammation in heart failure with reduced ejection fraction.
Bunsawat K; Ratchford SM; Alpenglow JK; Park SH; Jarrett CL; Stehlik J; Smith AS; Richardson RS; Wray DW
J Appl Physiol (1985); 2021 Jan; 130(1):256-268. PubMed ID: 33211601
[TBL] [Abstract][Full Text] [Related]
36. Factors determining training-induced changes in V̇O
Korzeniewski B; Rossiter HB
J Appl Physiol (1985); 2021 Feb; 130(2):498-507. PubMed ID: 33211591
[TBL] [Abstract][Full Text] [Related]
37. Cellular and molecular pathobiology of heart failure with preserved ejection fraction.
Mishra S; Kass DA
Nat Rev Cardiol; 2021 Jun; 18(6):400-423. PubMed ID: 33432192
[TBL] [Abstract][Full Text] [Related]
38. Abnormal skeletal muscle blood flow, contractile mechanics and fibre morphology in a rat model of obese-HFpEF.
Espino-Gonzalez E; Tickle PG; Benson AP; Kissane RWP; Askew GN; Egginton S; Bowen TS
J Physiol; 2021 Feb; 599(3):981-1001. PubMed ID: 33347612
[TBL] [Abstract][Full Text] [Related]
39. Heart failure with preserved ejection fraction: strategies for disease management and emerging therapeutic approaches.
Toth PP; Gauthier D
Postgrad Med; 2021 Mar; 133(2):125-139. PubMed ID: 33283589
[TBL] [Abstract][Full Text] [Related]
40. Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
Mueller S; Winzer EB; Duvinage A; Gevaert AB; Edelmann F; Haller B; Pieske-Kraigher E; Beckers P; Bobenko A; Hommel J; Van de Heyning CM; Esefeld K; von Korn P; Christle JW; Haykowsky MJ; Linke A; Wisløff U; Adams V; Pieske B; van Craenenbroeck EM; Halle M;
JAMA; 2021 Feb; 325(6):542-551. PubMed ID: 33560320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
